Sutro Demonstrates Meaningful ADC Innovation with Five Presentations and One Poster at the 14th Annual World ADC Conference

On October 16, 2023 Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), reported that the company will have five presentations and one poster at the 14th Annual World ADC Conference, taking place in San Diego, October 16-19, 2023 (Press release, Sutro Biopharma, OCT 16, 2023, View Source [SID1234636015]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Presentation Details:
Development of Next Generation ADCs Using Novel Expression Platforms & Precise Conjugation
Presenter: Gang Yin
Date/Time: October 17, 2023, 12:00pm PT

Discovery of Novel Linker Payloads for Site-Specific ADCs with Improved Efficacy & Therapeutic Index
Presenter: Krishna Bajjuri
Date/Time: October 17, 2023, 2:00pm PT

Precision Engineering for Enhanced Therapeutic Index: Designing STRO-004, a Tissue Factor Targeted ADC for Broadened Efficacy & Safety
Presenter: Alice Yam
Date/Time: October 17, 2023, 5:30pm PT

Stress Free ADC Production with Cell-Free Technology
Presenter: Ganesh Vissvesvaran
Date/Time: October 18, 2023, 12:00pm PT

Preclinical Development of STRO-003, a ROR1 Targeting Antibody-Drug Conjugate for Treatment of Hematologic & Solid Cancers
Presenter: Helena Kiefel
Date/Time: October 18, 2023, 2:00pm PT

Poster Details:
Site-specific Dual Conjugation Enabled by an Integrated in vivo / in vitro Antibody Production Platform
Presenter: Miao Wen
Date/Time: October 17, 2023, 6:00pm PT

Following the event, the content will be made available in the Clinical/Scientific Presentation and Publication Highlights section of Sutro Biopharma’s website at www.sutrobio.com.